Enteric Autoantibodies and Gut Motility Disorders

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Increasing evidence suggests that a subset of gastrointestinal motility disorders is associated with the presence of circulating antibodies. These antibodies are directed against various molecular targets, the best known being anti-neuronal nuclear antibody (ANNA-1 or anti-Hu) associated with paraneoplastic motility disorders. There is also evidence that the presence of distinct autoantibody profiles is associated with non-paraneoplastic motility disorders. This review focuses on the types of antibodies associated with gastrointestinal motility disorders and the significance of these antibodies. Algorithms are suggested for the work-up and treatment of patients with circulating antibodies associated with gastrointestinal motility disorders.

Original languageEnglish (US)
Pages (from-to)397-410
Number of pages14
JournalGastroenterology Clinics of North America
Volume37
Issue number2
DOIs
StatePublished - Jun 2008

Fingerprint

Autoantibodies
Gastrointestinal Motility
Antibodies

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Enteric Autoantibodies and Gut Motility Disorders. / Kashyap, Purna C; Farrugia, Gianrico.

In: Gastroenterology Clinics of North America, Vol. 37, No. 2, 06.2008, p. 397-410.

Research output: Contribution to journalArticle

@article{293f3c50e5aa49f7b7dc61f862a2e2a9,
title = "Enteric Autoantibodies and Gut Motility Disorders",
abstract = "Increasing evidence suggests that a subset of gastrointestinal motility disorders is associated with the presence of circulating antibodies. These antibodies are directed against various molecular targets, the best known being anti-neuronal nuclear antibody (ANNA-1 or anti-Hu) associated with paraneoplastic motility disorders. There is also evidence that the presence of distinct autoantibody profiles is associated with non-paraneoplastic motility disorders. This review focuses on the types of antibodies associated with gastrointestinal motility disorders and the significance of these antibodies. Algorithms are suggested for the work-up and treatment of patients with circulating antibodies associated with gastrointestinal motility disorders.",
author = "Kashyap, {Purna C} and Gianrico Farrugia",
year = "2008",
month = "6",
doi = "10.1016/j.gtc.2008.02.005",
language = "English (US)",
volume = "37",
pages = "397--410",
journal = "Gastroenterology Clinics of North America",
issn = "0889-8553",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Enteric Autoantibodies and Gut Motility Disorders

AU - Kashyap, Purna C

AU - Farrugia, Gianrico

PY - 2008/6

Y1 - 2008/6

N2 - Increasing evidence suggests that a subset of gastrointestinal motility disorders is associated with the presence of circulating antibodies. These antibodies are directed against various molecular targets, the best known being anti-neuronal nuclear antibody (ANNA-1 or anti-Hu) associated with paraneoplastic motility disorders. There is also evidence that the presence of distinct autoantibody profiles is associated with non-paraneoplastic motility disorders. This review focuses on the types of antibodies associated with gastrointestinal motility disorders and the significance of these antibodies. Algorithms are suggested for the work-up and treatment of patients with circulating antibodies associated with gastrointestinal motility disorders.

AB - Increasing evidence suggests that a subset of gastrointestinal motility disorders is associated with the presence of circulating antibodies. These antibodies are directed against various molecular targets, the best known being anti-neuronal nuclear antibody (ANNA-1 or anti-Hu) associated with paraneoplastic motility disorders. There is also evidence that the presence of distinct autoantibody profiles is associated with non-paraneoplastic motility disorders. This review focuses on the types of antibodies associated with gastrointestinal motility disorders and the significance of these antibodies. Algorithms are suggested for the work-up and treatment of patients with circulating antibodies associated with gastrointestinal motility disorders.

UR - http://www.scopus.com/inward/record.url?scp=43549090615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43549090615&partnerID=8YFLogxK

U2 - 10.1016/j.gtc.2008.02.005

DO - 10.1016/j.gtc.2008.02.005

M3 - Article

C2 - 18499027

AN - SCOPUS:43549090615

VL - 37

SP - 397

EP - 410

JO - Gastroenterology Clinics of North America

JF - Gastroenterology Clinics of North America

SN - 0889-8553

IS - 2

ER -